ArticleRheumatology international2025
Musculoskeletal pain in an ageing population: a cross-sectional analysis of the Maastricht study.
Article in Rheumatology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Chronic Pain in Older Adults: Risk Factors and Prevention.Life (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To estimate the prevalence of musculoskeletal pain (MSP) across age groups in a Dutch population sample of middle-aged and older adults. Cross-sectional data of 8618 participants aged 40-75 years from The Maastricht Study was used. Participants reported any (≥ 1 day in the past month) and chronic (≥ 3 months) MSP. Additionally, the latter group reported pain locations (grouped in six pain regions) and intensity (visual analogue scale 1-10). Prevalence of any and (patterns of) chronic MSP were described across seven age groups. Logistic and multinominal regression analyses assessed associations of age groups with MSP, adjusted for sex or type 2 diabetes mellitus (T2DM). Interactions between age and sex or T2DM were tested. Prevalence of any and chronic MSP was 53% and 29%, respectively. Any MSP was less common in participants aged 70-75 years compared to those aged 40-44 years (OR = 0.80, 95% CI: 0.65-0.99). Chronic MSP plateaued after age 60 (range ORs 55-69 years 1.27-1.38). Neck/chest/shoulder (65%) and lower back (55%) were the most common chronic pain regions. Pain in four or more locations was reported by 43%, with no age-group differences. Sex and T2DM did not modify the relation between age group and chronic MSP. Mean pain intensity in those with chronic MSP (5.6, SD 1.7) was stable across age groups. The prevalence of chronic MSP seems not to increase further after the age of 60, possibly reflecting decreased work demands, altered pain perception, effective pain management, or selection bias of healthier older individuals.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.